Extremely instructive! 'Getevenitis' is deadly for biotech investors. Professionals run the game to beat retail out of their shares right before the big payday. Wear them down and wear them out is the game run against retail.
I suggest long investors in AVXL read the message board here on IHUB for RKDA and look at the chart. One will read the posts of investors bought in @ $6 held through the $3s and back up to $5 then sold right at $10 a few days ago and felt happy with a 66% gain for holding for a year or so. They got back to even and a good profit for a relative safe blue chip or ETF but not enough to keep one in the Biotech game, then Bam! They missed the run to $50 today! Some would have sold a the pop from $6 to $ 18 a few days ago and would have been patting themselves on the back when it pulled back to $11 yesterday. Bam! They missed the run to $50 today and likely more to come. One must know what they own and what the true potential is in a high risk Biotech or any high risk investment. You will not win them all so the winners need to be held for the 'Full Monte Carlo.'
The old addage of "One never goes broke taking a profit" just may not hold up in Biotech because one needs to get paid for the winners at the Full Monte payout to make up for the inevitable losers of the bunch.
Many investors in AVXL will have been conditioned like Dr. Pavlov's Dog to sell AVXL at $14-$16 just as the run is starting because of what happened in Oct/Nov 2015. But as we saw today in the Ag Biotech Stock if it gets to $15 it can go to $50 or $100 in a New York heartbeat. One needs to know the true potential of what they own. These stocks are too risky to be played for anything less than a multibagger. Read the Arcadia Bioscience IHUB message board from when it started the run late last week and this week. Look at the chart. Make your plans in advance on what to do on a big pop in AVXL and for goodness sakes do not easily or cheaply give up your positions you have fought long and hard to hold.
Soon AVXL may approach the asymptote as well. Top line on RETT may do it, other things like a surprize partnership agreement (do they EVER not come by surprize?)could do it as well.
LONG Anavex Life Sciences!
News 
Market Data 
Discover 
